• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物经鼻腔给药在人体内的处置模型。

Model of disposition of drugs administered into the human nasal cavity.

作者信息

Gonda I, Gipps E

机构信息

Department of Pharmacy, University of Sydney, NSW, Australia.

出版信息

Pharm Res. 1990 Jan;7(1):69-75. doi: 10.1023/a:1015891727080.

DOI:10.1023/a:1015891727080
PMID:2300539
Abstract

A mathematical model was developed to describe the rate processes involved in the disposition of drugs placed in their delivery systems into the human nasal cavity. The model contains first-order parallel and sequential irreversible rate processes representing the convective drug and carrier transport by fluid flow, mucociliary clearance and peristalsis, drug release and absorption, and decomposition of the drug prior to its appearance in the systemic circulation. The numerical values of the parameters used are based on literature data from clearance studies of nonabsorbable markers deposited in the human nasal cavity, and data obtained under a variety of experimental conditions are consistent with the model. The effect of bioadhesive carriers is successfully simulated by reducing the mucociliary clearance rate constants for the transport from the posterior part of the nose into the gastrointestinal tract. The simulation shows that bioadhesion improves bioavailability and reduces the variability in absorption which might be caused by a variable pattern of deposition in the nose. Variable bioavailability could result from removal of the drug from the nasal cavity by sniffing, blowing, or wiping the nose, leading to different drug residence times in the nose. The model simulations further suggest that drug decomposition in the nose, while lowering bioavailability, also reduces variable absorption due to variable residence times of the drug in the nose.

摘要

建立了一个数学模型,用于描述置于给药系统中的药物进入人体鼻腔后的处置过程中的速率过程。该模型包含一级平行和顺序不可逆速率过程,分别代表药物和载体通过流体流动、黏液纤毛清除和蠕动的对流运输、药物释放和吸收,以及药物在进入体循环之前的分解。所用参数的数值基于人体鼻腔内沉积的不可吸收标记物清除研究的文献数据,并且在各种实验条件下获得的数据与该模型一致。通过降低从鼻腔后部进入胃肠道的运输的黏液纤毛清除速率常数,成功模拟了生物黏附载体的作用。模拟结果表明,生物黏附提高了生物利用度,并降低了可能因鼻腔内沉积模式变化而导致的吸收变异性。可变的生物利用度可能是由于通过嗅、擤或擦鼻从鼻腔中清除药物,导致药物在鼻腔中的停留时间不同。模型模拟进一步表明,药物在鼻腔中的分解虽然降低了生物利用度,但也减少了由于药物在鼻腔中停留时间变化而导致的可变吸收。

相似文献

1
Model of disposition of drugs administered into the human nasal cavity.药物经鼻腔给药在人体内的处置模型。
Pharm Res. 1990 Jan;7(1):69-75. doi: 10.1023/a:1015891727080.
2
Nasal clearance in health and disease.健康与疾病状态下的鼻腔清除功能。
J Aerosol Med. 2006 Spring;19(1):92-9. doi: 10.1089/jam.2006.19.92.
3
Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs.用于根据药物的体外跨细胞通透性预测鼻腔给药药物吸收的动力学模型。
Biol Pharm Bull. 2007 May;30(5):1007-10. doi: 10.1248/bpb.30.1007.
4
Mathematical modeling of deposition and disposition of drugs administered via the nose.经鼻给药药物沉积与处置的数学模型
Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):179-184. doi: 10.1016/s0169-409x(97)00068-9.
5
The nasal mucociliary clearance: relevance to nasal drug delivery.鼻黏膜纤毛清除:与鼻腔给药的相关性。
Pharm Res. 1991 Jul;8(7):807-14. doi: 10.1023/a:1015830907632.
6
Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics.将悬浮型鼻喷雾剂药物沉积模式与药代动力学特征相联系:一项使用计算流体动力学的概念验证研究
J Pharm Sci. 2016 Jun;105(6):1995-2004. doi: 10.1016/j.xphs.2016.03.033.
7
[Development of Prediction System for Drug Absorption after Intranasal Administration Incorporating Physiologic Functions of Nose -Estimation of in Vivo Drug Permeation through Nasal Mucosa Using in Vitro Membrane Permeability].[结合鼻腔生理功能的鼻内给药后药物吸收预测系统的开发——利用体外膜通透性估计体内药物经鼻黏膜的渗透]
Yakugaku Zasshi. 2021;141(11):1235-1240. doi: 10.1248/yakushi.21-00151.
8
Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.鼻腔给药后大鼠鼻腔和胃肠道对药物吸收贡献的评估。
Biol Pharm Bull. 2007 Mar;30(3):608-11. doi: 10.1248/bpb.30.608.
9
Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations.正常和双向鼻内给药技术的鼻腔和嗅觉沉积:体外试验与数值模拟
J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):118-131. doi: 10.1089/jamp.2016.1295. Epub 2016 Dec 15.
10
Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Development of a CFD Model.人体鼻腔中药物气雾剂的吸收与清除:计算流体动力学模型的开发
J Aerosol Med Pulm Drug Deliv. 2016 Oct;29(5):416-431. doi: 10.1089/jamp.2015.1252. Epub 2016 Jan 29.

引用本文的文献

1
Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal.用于模拟芬太尼呼吸抑制及相关纳洛酮逆转作用的全身生理模型。
Commun Med (Lond). 2024 Jun 12;4(1):114. doi: 10.1038/s43856-024-00536-5.
2
A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.一种用于表征鼻腔混悬剂药物产品的形态导向拉曼光谱方法学的系统方法。
AAPS J. 2021 May 18;23(4):73. doi: 10.1208/s12248-021-00605-w.
3
Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.

本文引用的文献

1
Intranasal and oral cocaine kinetics.鼻内和口服可卡因的动力学。
Clin Pharmacol Ther. 1980 Mar;27(3):386-94. doi: 10.1038/clpt.1980.52.
2
Mechanism of nasal absorption of drugs I: Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats.药物的鼻腔吸收机制I:影响大鼠鼻腔原位药物吸收速率的物理化学参数
J Pharm Sci. 1985 Jun;74(6):608-11. doi: 10.1002/jps.2600740605.
3
Effects of dose, pH, and osmolarity on nasal absorption of secretin in rats.
经鼻给予局部作用左氧氟沙星至大鼠:概念验证药代动力学研究。
Pharm Res. 2017 Nov;34(11):2260-2269. doi: 10.1007/s11095-017-2232-1. Epub 2017 Jul 26.
4
Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics.将悬浮型鼻喷雾剂药物沉积模式与药代动力学特征相联系:一项使用计算流体动力学的概念验证研究
J Pharm Sci. 2016 Jun;105(6):1995-2004. doi: 10.1016/j.xphs.2016.03.033.
5
Current understanding of nasal morphology and physiology as a drug delivery target.目前对鼻腔形态和生理学作为药物传递靶点的理解。
Drug Deliv Transl Res. 2013 Feb;3(1):4-15. doi: 10.1007/s13346-012-0121-z.
6
Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.作为鼻腔沉积替代物的水性喷雾泵体外测试的有效性。
Pharm Res. 2002 Jan;19(1):1-6. doi: 10.1023/a:1013643912335.
7
The nasal mucociliary clearance: relevance to nasal drug delivery.鼻黏膜纤毛清除:与鼻腔给药的相关性。
Pharm Res. 1991 Jul;8(7):807-14. doi: 10.1023/a:1015830907632.
8
Microparticles of polyvinyl alcohol for nasal delivery. I. Generation by spray-drying and spray-desolvation.用于鼻腔给药的聚乙烯醇微粒。I. 通过喷雾干燥和喷雾去溶剂化制备
Pharm Res. 1992 Oct;9(10):1330-5. doi: 10.1023/a:1015869704171.
J Pharm Sci. 1985 May;74(5):550-2. doi: 10.1002/jps.2600740511.
4
Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.多肽的鼻腔给药 I:大鼠中脑啡肽的鼻腔吸收
J Pharm Sci. 1985 Apr;74(4):394-8. doi: 10.1002/jps.2600740406.
5
Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation.
J Pharm Sci. 1986 May;75(5):433-8. doi: 10.1002/jps.2600750502.
6
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
J Pharm Sci. 1988 Apr;77(4):337-9. doi: 10.1002/jps.2600770412.
7
Intranasal drug delivery for systemic medications.用于全身用药的鼻内给药
Crit Rev Ther Drug Carrier Syst. 1987;4(2):67-194.
8
Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.肽类药物的鼻腔给药:去氨加压素的鼻腔沉积、生物学反应及吸收
J Pharm Sci. 1986 Nov;75(11):1085-8. doi: 10.1002/jps.2600751113.
9
Enzymatic barriers to peptide and protein absorption.肽和蛋白质吸收的酶屏障
Crit Rev Ther Drug Carrier Syst. 1988;5(2):69-97.
10
Intranasal drug delivery by spray and drops.通过喷雾和滴剂进行鼻内给药。
J Pharm Pharmacol. 1985 May;37(5):294-7. doi: 10.1111/j.2042-7158.1985.tb05069.x.